Received Mar 18, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| TYP | TYPHOID LIVE ORAL TY21A (VIVOTIF) | BERNA BIOTECH, LTD. | 3 | Unknown | — |
Patient ate food half an hour after taking his third dose of the Vivotif; Case reference number US-BN-2025-001801 is a spontaneous case initially received from a nurse via Bavarian Nordic (reference number: CASE-000745) on 14-Nov-2025 and concerns a 19-years-old male patient. The patient's medical history and concomitant medications details were provided. On an unspecified date, the patient received the first and second dose of Vivotif vaccine (batch number: unknown), at unknown dose, route or site of administration for unknown indication. On an unspecified date, unknown time after the first dose, the patient ate, and half an hour later the patient took the third dose of vVvotif vaccine (batch number: unknown), at unknown dose, route or site of administration (explicitly coded as 'product administration error'). At the time of initial, it was unknown if the patient experienced any adverse event due to the Vivotif vaccination. Additional information received from nurse via Bavarian Nordicon 17-Nov-2025 included additional reported.; Reporter's Comments: A 19-year-old male patient ate, and half an hour later the patient took the third dose of Vivotif vaccine for unknown indication, which is considered as product administration error. It was unknown if the patient experienced any adverse event due to the Vivotif vaccination. Product administration error is considered as listed per company convention. The patient's medical history and concomitant medications details were provided. Product administration error is not related to the suspect vaccine, but to a human factor. This case is considered as non-serious.; Sender's Comments: A 19-year-old male patient ate, and half an hour later the patient took the third dose of Vivotif vaccine for unknown indication, which is considered as product administration error. It was unknown if the patient experienced any adverse event due to the Vivotif vaccination. Product administration error is considered as listed per company convention. The patient's medical history and concomitant medications details were provided. Product administration error is not related to the suspect vaccine, but to a human factor. This case is considered as non-serious.
Comments: None.